APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angelica Nanzao Granules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Angelica Nanzao Granules Market Outlook and Growth Opportunities 2026

26 December 2025192 pages

Choose your research edition.

Industry ResearchAngelica Nanzao Granules Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Angelica Nanzao Granules Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Angelica Nanzao Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angelica Nanzao Granules Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Angelica Nanzao Granules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Angelica Nanzao Granules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Angelica Nanzao Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Angelica Nanzao Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angelica Nanzao Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Angelica Nanzao Granules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Angelica Nanzao Granules market include Sichuan Rende Pharmaceutical Co., Ltd., Shandong Phoenix Pharmaceutical Co., Ltd., Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd., Jiangxi Yintao Pharmaceutical Co., Ltd., Jiangxi Rongyu Pharmaceutical Group Co., Ltd., Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group, Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. and Guangdong Kangqili Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Angelica Nanzao Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Angelica Nanzao Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Angelica Nanzao Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Angelica Nanzao Granules market size, projected growth trends, production technologies, key applications, and end-use industries.

Angelica Nanzao Granules Segment by Company

Sichuan Rende Pharmaceutical Co., Ltd.

Shandong Phoenix Pharmaceutical Co., Ltd.

Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd.

Jiangxi Yintao Pharmaceutical Co., Ltd.

Jiangxi Rongyu Pharmaceutical Group Co., Ltd.

Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group

Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd.

Guangdong Kangqili Pharmaceutical Co., Ltd.

Angelica Nanzao Granules Segment by Type

Pack of 8

Pack of 10

Angelica Nanzao Granules Segment by Application

Hospital

Clinic

Other

Angelica Nanzao Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Angelica Nanzao Granules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Angelica Nanzao Granules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Angelica Nanzao Granules significant trends, drivers, influence factors in global and regions.

6. To analyze Angelica Nanzao Granules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angelica Nanzao Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angelica Nanzao Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angelica Nanzao Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angelica Nanzao Granules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Angelica Nanzao Granules industry.

Chapter 3: Detailed analysis of Angelica Nanzao Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Angelica Nanzao Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Angelica Nanzao Granules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Angelica Nanzao Granules Industry Trends Table 2. Angelica Nanzao Granules Industry Drivers Table 3. Angelica Nanzao Granules Industry Opportunities and Challenges Table 4. Angelica Nanzao Granules Industry Restraints Table 5. Global Angelica Nanzao Granules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Angelica Nanzao Granules Revenue Share by Company (2021-2026) Table 7. Global Angelica Nanzao Granules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Angelica Nanzao Granules Sales Volume Share by Company (2021-2026) Table 9. Global Angelica Nanzao Granules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Angelica Nanzao Granules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Angelica Nanzao Granules Key Company Manufacturing Base & Headquarters Table 12. Global Angelica Nanzao Granules Company, Product Type & Application Table 13. Global Angelica Nanzao Granules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Angelica Nanzao Granules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pack of 8 Table 18. Significant Companies of Pack of 10 Table 19. Global Angelica Nanzao Granules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Angelica Nanzao Granules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Angelica Nanzao Granules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Angelica Nanzao Granules Sales Volume Share by Type (2021-2026) Table 23. Global Angelica Nanzao Granules Sales Volume Share by Type (2027-2032) Table 24. Global Angelica Nanzao Granules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Angelica Nanzao Granules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Angelica Nanzao Granules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Angelica Nanzao Granules Sales Value Share by Type (2021-2026) Table 28. Global Angelica Nanzao Granules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Angelica Nanzao Granules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Angelica Nanzao Granules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Angelica Nanzao Granules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Angelica Nanzao Granules Sales Volume Share by Application (2021-2026) Table 36. Global Angelica Nanzao Granules Sales Volume Share by Application (2027-2032) Table 37. Global Angelica Nanzao Granules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Angelica Nanzao Granules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Angelica Nanzao Granules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Angelica Nanzao Granules Sales Value Share by Application (2021-2026) Table 41. Global Angelica Nanzao Granules Sales Value Share by Application (2027-2032) Table 42. Global Angelica Nanzao Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Angelica Nanzao Granules Sales by Region (2021-2026) & (K Units) Table 44. Global Angelica Nanzao Granules Sales Market Share by Region (2021-2026) Table 45. Global Angelica Nanzao Granules Sales by Region (2027-2032) & (K Units) Table 46. Global Angelica Nanzao Granules Sales Market Share by Region (2027-2032) Table 47. Global Angelica Nanzao Granules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Angelica Nanzao Granules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Angelica Nanzao Granules Sales Value Share by Region (2021-2026) Table 50. Global Angelica Nanzao Granules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Angelica Nanzao Granules Sales Value Share by Region (2027-2032) Table 52. Global Angelica Nanzao Granules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Angelica Nanzao Granules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Angelica Nanzao Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Angelica Nanzao Granules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Angelica Nanzao Granules Sales by Country (2021-2026) & (K Units) Table 57. Global Angelica Nanzao Granules Sales Market Share by Country (2021-2026) Table 58. Global Angelica Nanzao Granules Sales by Country (2027-2032) & (K Units) Table 59. Global Angelica Nanzao Granules Sales Market Share by Country (2027-2032) Table 60. Global Angelica Nanzao Granules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Angelica Nanzao Granules Sales Value Market Share by Country (2021-2026) Table 62. Global Angelica Nanzao Granules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Angelica Nanzao Granules Sales Value Market Share by Country (2027-2032) Table 64. Sichuan Rende Pharmaceutical Co., Ltd. Company Information Table 65. Sichuan Rende Pharmaceutical Co., Ltd. Business Overview Table 66. Sichuan Rende Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sichuan Rende Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 68. Sichuan Rende Pharmaceutical Co., Ltd. Recent Development Table 69. Shandong Phoenix Pharmaceutical Co., Ltd. Company Information Table 70. Shandong Phoenix Pharmaceutical Co., Ltd. Business Overview Table 71. Shandong Phoenix Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shandong Phoenix Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 73. Shandong Phoenix Pharmaceutical Co., Ltd. Recent Development Table 74. Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Company Information Table 75. Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Business Overview Table 76. Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 78. Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Recent Development Table 79. Jiangxi Yintao Pharmaceutical Co., Ltd. Company Information Table 80. Jiangxi Yintao Pharmaceutical Co., Ltd. Business Overview Table 81. Jiangxi Yintao Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Jiangxi Yintao Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 83. Jiangxi Yintao Pharmaceutical Co., Ltd. Recent Development Table 84. Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Company Information Table 85. Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Business Overview Table 86. Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 88. Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Recent Development Table 89. Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Company Information Table 90. Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Business Overview Table 91. Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Angelica Nanzao Granules Product Portfolio Table 93. Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Recent Development Table 94. Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Company Information Table 95. Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Business Overview Table 96. Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 98. Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Recent Development Table 99. Guangdong Kangqili Pharmaceutical Co., Ltd. Company Information Table 100. Guangdong Kangqili Pharmaceutical Co., Ltd. Business Overview Table 101. Guangdong Kangqili Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Guangdong Kangqili Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio Table 103. Guangdong Kangqili Pharmaceutical Co., Ltd. Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Angelica Nanzao Granules Distributors List Table 107. Angelica Nanzao Granules Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Angelica Nanzao Granules Product Image Figure 2. Global Angelica Nanzao Granules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angelica Nanzao Granules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Angelica Nanzao Granules Sales (2021-2032) & (K Units) Figure 5. Global Angelica Nanzao Granules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Angelica Nanzao Granules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pack of 8 Image Figure 10. Pack of 10 Image Figure 11. Global Angelica Nanzao Granules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Angelica Nanzao Granules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Angelica Nanzao Granules Sales Volume Share by Type (2021-2032) Figure 14. Global Angelica Nanzao Granules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Angelica Nanzao Granules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Angelica Nanzao Granules Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Angelica Nanzao Granules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Angelica Nanzao Granules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Angelica Nanzao Granules Sales Volume Share by Application (2021-2032) Figure 23. Global Angelica Nanzao Granules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Angelica Nanzao Granules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Angelica Nanzao Granules Sales Value Share by Application (2021-2032) Figure 26. Global Angelica Nanzao Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Angelica Nanzao Granules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Angelica Nanzao Granules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Angelica Nanzao Granules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Angelica Nanzao Granules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Angelica Nanzao Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Angelica Nanzao Granules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Angelica Nanzao Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Angelica Nanzao Granules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Angelica Nanzao Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Angelica Nanzao Granules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Angelica Nanzao Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Angelica Nanzao Granules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Angelica Nanzao Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Angelica Nanzao Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Angelica Nanzao Granules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Angelica Nanzao Granules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Pack of 8
  • Pack of 10
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sichuan Rende Pharmaceutical Co., Ltd.
  • Shandong Phoenix Pharmaceutical Co., Ltd.
  • Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd.
  • Jiangxi Yintao Pharmaceutical Co., Ltd.
  • Jiangxi Rongyu Pharmaceutical Group Co., Ltd.
  • Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group
  • Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd.
  • Guangdong Kangqili Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angelica Nanzao Granules Sales Value (2021-2032)
  4. 1.2.2 Global Angelica Nanzao Granules Sales Volume (2021-2032)
  5. 1.2.3 Global Angelica Nanzao Granules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Angelica Nanzao Granules Market Dynamics
  1. 2.1 Angelica Nanzao Granules Industry Trends
  2. 2.2 Angelica Nanzao Granules Industry Drivers
  3. 2.3 Angelica Nanzao Granules Industry Opportunities and Challenges
  4. 2.4 Angelica Nanzao Granules Industry Restraints
3 Angelica Nanzao Granules Market by Company
  1. 3.1 Global Angelica Nanzao Granules Company Revenue Ranking in 2025
  2. 3.2 Global Angelica Nanzao Granules Revenue by Company (2021-2026)
  3. 3.3 Global Angelica Nanzao Granules Sales Volume by Company (2021-2026)
  4. 3.4 Global Angelica Nanzao Granules Average Price by Company (2021-2026)
  5. 3.5 Global Angelica Nanzao Granules Company Ranking (2024-2026)
  6. 3.6 Global Angelica Nanzao Granules Company Manufacturing Base and Headquarters
  7. 3.7 Global Angelica Nanzao Granules Company Product Type and Application
  8. 3.8 Global Angelica Nanzao Granules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Angelica Nanzao Granules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Angelica Nanzao Granules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Angelica Nanzao Granules Market by Type
  1. 4.1 Angelica Nanzao Granules Type Introduction
  2. 4.1.1 Pack of 8
  3. 4.1.2 Pack of 10
  4. 4.2 Global Angelica Nanzao Granules Sales Volume by Type
  5. 4.2.1 Global Angelica Nanzao Granules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Angelica Nanzao Granules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Angelica Nanzao Granules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Angelica Nanzao Granules Sales Value by Type
  9. 4.3.1 Global Angelica Nanzao Granules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Angelica Nanzao Granules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Angelica Nanzao Granules Sales Value Share by Type (2021-2032)
5 Angelica Nanzao Granules Market by Application
  1. 5.1 Angelica Nanzao Granules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Angelica Nanzao Granules Sales Volume by Application
  6. 5.2.1 Global Angelica Nanzao Granules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Angelica Nanzao Granules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Angelica Nanzao Granules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Angelica Nanzao Granules Sales Value by Application
  10. 5.3.1 Global Angelica Nanzao Granules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Angelica Nanzao Granules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Angelica Nanzao Granules Sales Value Share by Application (2021-2032)
6 Angelica Nanzao Granules Regional Sales and Value Analysis
  1. 6.1 Global Angelica Nanzao Granules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Angelica Nanzao Granules Sales by Region (2021-2032)
  3. 6.2.1 Global Angelica Nanzao Granules Sales by Region: 2021-2026
  4. 6.2.2 Global Angelica Nanzao Granules Sales by Region (2027-2032)
  5. 6.3 Global Angelica Nanzao Granules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Angelica Nanzao Granules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Angelica Nanzao Granules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Angelica Nanzao Granules Sales Value by Region (2027-2032)
  9. 6.5 Global Angelica Nanzao Granules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Angelica Nanzao Granules Sales Value (2021-2032)
  12. 6.6.2 North America Angelica Nanzao Granules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Angelica Nanzao Granules Sales Value (2021-2032)
  15. 6.7.2 Europe Angelica Nanzao Granules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Angelica Nanzao Granules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Angelica Nanzao Granules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Angelica Nanzao Granules Sales Value (2021-2032)
  21. 6.9.2 South America Angelica Nanzao Granules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Angelica Nanzao Granules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Angelica Nanzao Granules Sales Value Share by Country, 2025 VS 2032
7 Angelica Nanzao Granules Country-level Sales and Value Analysis
  1. 7.1 Global Angelica Nanzao Granules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Angelica Nanzao Granules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Angelica Nanzao Granules Sales by Country (2021-2032)
  4. 7.3.1 Global Angelica Nanzao Granules Sales by Country (2021-2026)
  5. 7.3.2 Global Angelica Nanzao Granules Sales by Country (2027-2032)
  6. 7.4 Global Angelica Nanzao Granules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Angelica Nanzao Granules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Angelica Nanzao Granules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Angelica Nanzao Granules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Angelica Nanzao Granules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Angelica Nanzao Granules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sichuan Rende Pharmaceutical Co., Ltd.
  2. 8.1.1 Sichuan Rende Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Sichuan Rende Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Sichuan Rende Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Rende Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio
  6. 8.1.5 Sichuan Rende Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Shandong Phoenix Pharmaceutical Co., Ltd.
  8. 8.2.1 Shandong Phoenix Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Shandong Phoenix Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Shandong Phoenix Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Phoenix Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio
  12. 8.2.5 Shandong Phoenix Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd.
  14. 8.3.1 Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio
  18. 8.3.5 Qinghai Qiying Hanzang Biopharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Jiangxi Yintao Pharmaceutical Co., Ltd.
  20. 8.4.1 Jiangxi Yintao Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Jiangxi Yintao Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Jiangxi Yintao Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangxi Yintao Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio
  24. 8.4.5 Jiangxi Yintao Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Jiangxi Rongyu Pharmaceutical Group Co., Ltd.
  26. 8.5.1 Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Company Information
  27. 8.5.2 Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Business Overview
  28. 8.5.3 Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Angelica Nanzao Granules Product Portfolio
  30. 8.5.5 Jiangxi Rongyu Pharmaceutical Group Co., Ltd. Recent Developments
  31. 8.6 Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group
  32. 8.6.1 Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Company Information
  33. 8.6.2 Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Business Overview
  34. 8.6.3 Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Angelica Nanzao Granules Product Portfolio
  36. 8.6.5 Guangdong Global Pharmaceutical Co., Ltd. of Sinopharm Group Recent Developments
  37. 8.7 Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd.
  38. 8.7.1 Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Company Information
  39. 8.7.2 Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Business Overview
  40. 8.7.3 Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Angelica Nanzao Granules Product Portfolio
  42. 8.7.5 Guangzhou Baiyunshan Xingqun (Pharmaceutical) Co., Ltd. Recent Developments
  43. 8.8 Guangdong Kangqili Pharmaceutical Co., Ltd.
  44. 8.8.1 Guangdong Kangqili Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Guangdong Kangqili Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Guangdong Kangqili Pharmaceutical Co., Ltd. Angelica Nanzao Granules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Kangqili Pharmaceutical Co., Ltd. Angelica Nanzao Granules Product Portfolio
  48. 8.8.5 Guangdong Kangqili Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Angelica Nanzao Granules Value Chain Analysis
  2. 9.1.1 Angelica Nanzao Granules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Angelica Nanzao Granules Sales Mode & Process
  6. 9.2 Angelica Nanzao Granules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Angelica Nanzao Granules Distributors
  9. 9.2.3 Angelica Nanzao Granules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst